Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies
収録刊行物
-
- Clinical Cancer Research
-
Clinical Cancer Research 13 3913-3921, 2007